Moors & Cabot, Inc. Amicus Therapeutics, Inc. Transaction History

Moors & Cabot, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 22, 2019	SELL	$8.02 - $13.25 $92,631 - $153,037	-11,550 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$10.04 - $13.92 $115,961 - $160,776	-11,550 Reduced 50.0%	11,550 $160,000
Q1 2019 May 01, 2019	BUY	$10.04 - $13.92 $105,921 - $146,856	10,550 Added 84.06%	23,100 $320,000
Q4 2018 Feb 13, 2019	SELL	$8.38 - $13.44 $33,520 - $53,760	-4,000 Reduced 24.17%	12,550 $123,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $191,980 - $273,737	16,550 New	16,550 $198,000

312

311M

467K

515K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.57B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.